Loading…
Reported covered position: Intern, Senator Toomey (R-PA) - August 2014 - May 2015.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
For the People Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CHAMBER OF COMMERCE OF THE U.S.A. via CHAMBER OF COMMERCE OF THE U.S.A.
2021 · second_quarter · Q2
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Source: Senate LDA
Shareholder Political Transparency Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Corporate Governance Improvement and Investor Protection Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Cyber Diplomacy Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
Improving Corporate Governance Through Diversity Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
American Rescue Plan Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
American Rescue Plan Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
American Rescue Plan Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1319, American Rescue Plan Act of 2021 S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Merrick Garland to be Attorney General Petition for rulemaking on support for COVID-19 related litigation - File 4-766; Various issues relating to liability relief due to the coronavirus pandemic; comments on support for petition for rulemaking on COVID-19 related litigation - File 4-766; Background on and preservation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Justice for Black Farmers Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Information Transparency & Personal Data Control Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
Litigation Funding Transparency Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
SACKLER Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 2096, Stop shielding Assets from Corporate Known Liability by Eliminating non-debtor Releases (SACKLER) Act Potential legislation similar to S. 766, Providing Responsible Oversight of Trusts to Ensure Compensation and Transparency (PROTECT) Asbestos Victims Act of 2019 Various issues relating to the U.S. Trustees authority to oversee the administration of bankruptcy trust funds; litigation bankruptcy trusts
Driving for Opportunity Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Promoting Diversity and Inclusion in Banking Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Federal Reserve Racial and Economic Equity Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Comprehensive Debt Collection Improvement Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Comprehensive Debt Collection Improvement Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Climate Risk Disclosure Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
PFAS Accountability Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Fairness in Nursing Home Arbitration Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Carrie’s Law
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Disclosure of Tax Havens and Offshoring Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Ending Forced Arbitration for Victims of Data Breaches Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Alleviating Stress Test Burdens To Help Investors Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Helping Startups Continue To Grow Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Modernizing Disclosures for Investors Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
State Antitrust Enforcement Venue Act of 2022
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
Infrastructure Investment and Jobs Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Unfunded Mandates Accountability and Transparency Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
Promoting Digital Privacy Technologies Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
RISE Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
FAIR Act of 2022
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
FAIR Act of 2022
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1319, American Rescue Plan Act of 2021 S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Merrick Garland to be Attorney General Petition for rulemaking on support for COVID-19 related litigation - File 4-766; Various issues relating to liability relief due to the coronavirus pandemic; comments on support for petition for rulemaking on COVID-19 related litigation - File 4-766; Background on and preservation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Balancing the Rights Of Web Surfers Equally and Responsibly Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
PFAS Accountability Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
State Antitrust Enforcement Venue Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
For the People Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
Promoting Digital Privacy Technologies Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
RISE Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
Justice for Black Farmers Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Improving Corporate Governance Through Diversity Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
Forced Arbitration Injustice Repeal Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1319, American Rescue Plan Act of 2021 S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Merrick Garland to be Attorney General Petition for rulemaking on support for COVID-19 related litigation - File 4-766; Various issues relating to liability relief due to the coronavirus pandemic; comments on support for petition for rulemaking on COVID-19 related litigation - File 4-766; Background on and preservation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Forced Arbitration Injustice Repeal Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
VAWA Technical Amendment Act of 2022
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Open and Responsive Government Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Open and Responsive Government Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1319, American Rescue Plan Act of 2021 S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Merrick Garland to be Attorney General Petition for rulemaking on support for COVID-19 related litigation - File 4-766; Various issues relating to liability relief due to the coronavirus pandemic; comments on support for petition for rulemaking on COVID-19 related litigation - File 4-766; Background on and preservation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Open and Responsive Government Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
Litigation Funding Transparency Act of 2021
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
COVID-19 Hate Crimes Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders".
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
Alan Reinstein Ban Asbestos Now Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1319, American Rescue Plan Act of 2021 S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Merrick Garland to be Attorney General Petition for rulemaking on support for COVID-19 related litigation - File 4-766; Various issues relating to liability relief due to the coronavirus pandemic; comments on support for petition for rulemaking on COVID-19 related litigation - File 4-766; Background on and preservation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Alan Reinstein Ban Asbestos Now Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
DETOUR Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
AMICUS Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
LOCAL Infrastructure Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
PROTECT Asbestos Victims Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
Potential legislation similar to S. 766, Providing Responsible Oversight of Trusts to Ensure Compensation and Transparency (PROTECT) Asbestos Victims Act of 2019 Various issues relating to the U.S. Trustees authority to oversee the administration of bankruptcy trust funds; litigation bankruptcy trusts
PROTECT Asbestos Victims Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 2096, Stop shielding Assets from Corporate Known Liability by Eliminating non-debtor Releases (SACKLER) Act Potential legislation similar to S. 766, Providing Responsible Oversight of Trusts to Ensure Compensation and Transparency (PROTECT) Asbestos Victims Act of 2019 Various issues relating to the U.S. Trustees authority to oversee the administration of bankruptcy trust funds; litigation bankruptcy trusts
Ending Forced Arbitration of Sexual Harassment Act of 2017
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1393/S. 300, Justice for Black Farmers Act of 2021 H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2751/S. 1334, PFAS Accountability Act of 2021 H.R. 2812, Fairness in Nursing Home Arbitration Act H.R. 2906, Carries Law H.R. 3280, Ending Forced Arbitration for Victims of Data Breaches Act of 2021 H.R. 3684, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes S. 937, COVID-19 Hate Crimes Act Potential legislation similar to S. 2203, Ending Forced Arbitration of Sexual Harassment Act of 2017 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); implementation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; potential arbitration legislation; fraud and abuse in civil litigation
Medicare Buy-In and Health Care Stabilization Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
Medicare Buy-In and Health Care Stabilization Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Medicare Buy-In and Health Care Stabilization Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Medicare Buy-In and Health Care Stabilization Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Medicare for All Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Medicare for All Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Medicare for All Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
Medicare for All Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Health Insurance Tax Relief Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
Health Insurance Tax Relief Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Health Insurance Tax Relief Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Health Insurance Tax Relief Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
FAIR Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1423/S. 610, Forced Arbitration Injustice Repeal Act H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 2750, Justice for Servicemembers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 5326, Fairness in Nursing Home Arbitration Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 8222, Infrastructure Expansion Act of 2020 H.R. 8608, Carries Law S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; arbitration agreements and implementation of the Servicemembers Civil Relief Act (P.L. 108-189) and the Uniformed Services Employment and Reemployment Rights Act of 1994 (P.L. 103-353); implementation of Foreign Corrupt Practices Act (P.L. 95-213); implementation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation; asbestos risk assessment report
FAIR Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
FAIR Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
FAIR Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Patient Protection and Affordable Care Enhancement Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
Patient Protection and Affordable Care Enhancement Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Patient Protection and Affordable Care Enhancement Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Patient Protection and Affordable Care Enhancement Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Court Legal Access and Student Support (CLASS) Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Court Legal Access and Student Support (CLASS) Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Court Legal Access and Student Support (CLASS) Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1423/S. 610, Forced Arbitration Injustice Repeal Act H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 2750, Justice for Servicemembers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 5326, Fairness in Nursing Home Arbitration Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 8222, Infrastructure Expansion Act of 2020 H.R. 8608, Carries Law S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; arbitration agreements and implementation of the Servicemembers Civil Relief Act (P.L. 108-189) and the Uniformed Services Employment and Reemployment Rights Act of 1994 (P.L. 103-353); implementation of Foreign Corrupt Practices Act (P.L. 95-213); implementation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation; asbestos risk assessment report
Court Legal Access and Student Support (CLASS) Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Ending Forced Arbitration of Sexual Harassment Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1423/S. 610, Forced Arbitration Injustice Repeal Act H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 2750, Justice for Servicemembers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 5326, Fairness in Nursing Home Arbitration Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 8222, Infrastructure Expansion Act of 2020 H.R. 8608, Carries Law S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; arbitration agreements and implementation of the Servicemembers Civil Relief Act (P.L. 108-189) and the Uniformed Services Employment and Reemployment Rights Act of 1994 (P.L. 103-353); implementation of Foreign Corrupt Practices Act (P.L. 95-213); implementation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation; asbestos risk assessment report
Ending Forced Arbitration of Sexual Harassment Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Ending Forced Arbitration of Sexual Harassment Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Ending Forced Arbitration of Sexual Harassment Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Consumers First Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Consumers First Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1423/S. 610, Forced Arbitration Injustice Repeal Act H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 2750, Justice for Servicemembers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 5326, Fairness in Nursing Home Arbitration Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 8222, Infrastructure Expansion Act of 2020 H.R. 8608, Carries Law S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; arbitration agreements and implementation of the Servicemembers Civil Relief Act (P.L. 108-189) and the Uniformed Services Employment and Reemployment Rights Act of 1994 (P.L. 103-353); implementation of Foreign Corrupt Practices Act (P.L. 95-213); implementation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation; asbestos risk assessment report
Consumers First Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Consumers First Act
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Alan Reinstein Ban Asbestos Now Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1423/S. 610, Forced Arbitration Injustice Repeal Act H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 2750, Justice for Servicemembers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 5326, Fairness in Nursing Home Arbitration Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 8222, Infrastructure Expansion Act of 2020 H.R. 8608, Carries Law S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; arbitration agreements and implementation of the Servicemembers Civil Relief Act (P.L. 108-189) and the Uniformed Services Employment and Reemployment Rights Act of 1994 (P.L. 103-353); implementation of Foreign Corrupt Practices Act (P.L. 95-213); implementation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation; asbestos risk assessment report
Alan Reinstein Ban Asbestos Now Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Alan Reinstein Ban Asbestos Now Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Alan Reinstein Ban Asbestos Now Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Save the Internet Act of 2019
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 739, Cyber Diplomacy Act of 2019 H.R. 946, Stopping Bad Robocalls Act H.R. 1644, Save the Internet Act of 2019 H.R. 2013, Information Transparency & Personal Data Control Act H.R. 2202, Growing Artificial Intelligence Through Research (GrAITR) Act H.R. 2575/S. 1363, AI in Government Act of 2019 H.R. 3086/S. 1585, Respond, Innovate, Succeed, and Empower (RISE) Act of 2019 H.R. 3156, Smart Technologies Advancing Reliable Transportation (START) Act H.R. 3262/H.R. 4686/ S. 1871, Sami's Law H.R. 4027, Stop the Censorship Act H.R. 4978, Online Privacy Act of 2019 H.R. 5703, Protecting the Information of our Vulnerable Children and Youth (PRIVCY) Act H.R. 6145/S. 3191, Industries of the Future Act of 2020 H.R. 6216, National Artificial Intelligence Initiative Act of 2020 H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 7308/ S. 4286, Research Investment to Spark the Economy (RISE) Act H.R. 7608, State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021 H.R. 8048, State and Local IT Modernization and Cybersecurity Act H.R. 8132, American Competitiveness Of a More Productive Emerging Tech Economy (American COMPETE) Act H.R. 8517, Protect Speech Act H.R. 8636, Protecting Americans from Dangerous Algorithms Act S. 142, American Data Dissemination (ADD) Act of 2019 S. 189, Social Media Privacy Protection and Consumer Rights Act of 2019 S. 583, Digital Accountability and Transparency to Advance (DATA) Privacy Act S. 748, A bill to amend the Children's Online Privacy Protection Act of 1998 to strengthen protections relating to the online collection, use, and disclosure of personal information of children and minors, and for other purposes S. 783, Clean Slate for Kids Online Act of 2019 S. 847, Commercial Facial Recognition Privacy Act of 2019 S. 1084, Deceptive Experiences To Online Users Reduction (DETOUR) Act S. 1116, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2019 S. 1214, Privacy Bill of Rights Act S. 1558, Artificial Intelligence Initiative Act S. 1578, Do Not Track Act S. 1611, Developing Innovation and Growing the Internet of Things (DIGIT) Act S. 1914, Ending Support for Internet Censorship Act S. 2775, Harvesting American Cybersecurity Knowledge through Education (HACKED) Act of 2019 S. 2763, Filter Bubble Transparency Act S. 2878, Facial Recognition Technology Warrant Act of 2019 S. 2968, Consumer Online Privacy Rights Act S. 3284, Ethical Use of Facial Recognition Act S. 3300, Data Protection Act of 2020 S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 S. 3456, Consumer Data Privacy and Security Act of 2020 S. 3663, COVID-19 Consumer Data Protection Act of 2020 S. 3712, Cybersecurity Competitions to Yield Better Efforts to Research the Latest Exceptionally Advanced Problems (Cyber Leap) Act of 2020 S. 3749, Public Health Emergency Privacy Act S. 3771, Fundamentally Understanding the Usability and Realistic Evolution (FUTURE) of Artificial Intelligence Act of 2020 S. 3832, Endless Frontier Act S. 3861, Exposure Notification Privacy Act S. 3891, Advancing Artificial Intelligence Research Act of 2020 S. 3983, A bill to amend the Communications Act of 1934 to provide accountability for bad actors who abuse the Good Samaritan protections provided under that Act, and for other purposes S. 4051, Lawful Access to Encrypted Data Act S. 4066, Platform Accountability and Consumer Transparency (PACT) Act S. 4159, E-SIGN Modernization Act of 2020 S. 4422, Connecting Minority Communities Act of 2020 S. 4626, Setting an American Framework to Ensure Data Access, Transparency, and Accountability (SAFE DATA) Act S. 4632, Online Content Policy Modernization Act S. 4758, See Something, Say Something Online Act of 2020 S. 5020, A bill to repeal section 230 of the Communications Act of 1934 H.Res. 294, Providing for consideration of the bill (H.R. 1644) to restore the open internet order of the Federal Communications Commission; providing for consideration of the bill (H.R. 2021) to amend the Balanced Budget and Emergency Deficit Control Act of 1985 and to establish a congressional budget for fiscal year 2020; and for other purposes Potential legislation similar to H.R.4625, FUTURE of Artificial Intelligence Act of 2017 Potential legislation related to the regulation of facial recognition technology Draft legislation titled FTC Procedural Reform Draft legislation titled United States Consumer Data Privacy Act of 2019 Proposed rule restoring internet freedom (82 Fed. Reg. 25,568-25,590, June 2, 2017) Proposed rule accelerating wireline broadband deployment by removing barriers to infrastructure investment (82 Fed. Reg. 22,453-22,474, May 16, 2017) Draft memorandum to the heads of executive departments and agencies, Guidance for Regulation of Artificial Intelligence Applications (85 Fed. Reg. 1,825, January 13, 2020); Various issues relating to high speed broadband internet service and resolving the homework gap by access to broadband for students; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; potential legislation to establish a national privacy law; matter of streamlining deployment of small cell infrastructure by improving wireless sitting policies (FCC WT Docket No. 16-421); comments on refreshing of record in restoring internet freedom proceeding (WC Docket Nos. 17-108, 17-287, 11-42); facial recognition technology; net neutrality; privacy principles; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC data portability; FTC enforcement; FTC enforcement of section 13(b); FCC proposed radiofrequency marketing rule; reauthorization and appropriation for the National Institute of Standards and Technology (NIST); FY2021 Appropriations for the National Institute of Standards and Technology (NIST); comments on March 30, 2020 Petition for Expedited Declaratory Ruling, Clarification or Waiver Filed by the American Bankers Association, et al. - CG Docket Number 02-278; comments on National Institute of Standards and Technology (NIST) NISTIR 8259, recommendations for IoT device Manufacturers: Foundational Activities and Core Device Cybersecurity Capability Baseline (2nd Draft); comments on the National Telecommunications and Information Administrations request for public comment on proposals and positions for the 2020 World Telecommunication Standardization Assembly; funding for the NIST AI risk management framework; FCCs COVID-19 telehealth program; Indias non-personal data governance framework; comments to Department of Transportation on remote identifications of unmanned aerial systems proposed rule; Transportation Network Companies (TNCs) and the coronavirus pandemic; comments on Four Principles of Explainable Artificial Intelligence (Draft NISTIR 8312); petition to FCC Supporting Capital Ones TCPA Petition for Declaratory Ruling; inclusion of broadband funding in year-end appropriations legislation; implementation Section 2209 of the FAA Extension, Safety, and Security Act of 2016 (P.L. 114-190); potential nationalization of the 5G network; comments on OMBs Guidance for Regulation of Artificial Intelligence Applications; potential data privacy legislation; potential data aggregation legislation regarding section 1033 of Dodd-Frank Wall Street Reform and Consumer Protection Act (P.L. 111-203); potential legislation regarding artificial intelligence; artificial intelligence regulation, research and development; potential legislation regarding digital assets; fintech and digital asset strategy; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising; implementation of Telephone Consumer Protection Act (TCPA) (P.L. 102-243)
Further Consolidated Appropriations Act, 2020
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
Further Consolidated Appropriations Act, 2020
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Further Consolidated Appropriations Act, 2020
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Further Consolidated Appropriations Act, 2020
Client: CHAMBER OF COMMERCE OF THE U.S.A. · Firm: CHAMBER OF COMMERCE OF THE U.S.A.
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
H.R. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 S. 742, Open and Responsive Government Act of 2021 S. 1411, Assessing Monetary Influence in the Courts of the United States (AMICUS) Act Nomination of Bill Nelson to be National Aeronautics and Space Administration Administrator Nomination of Dilawar Syed to be Deputy Administrator of the U.S. Small Business Administration Nomination of Ur Mendoza Jaddou to be the Director of U.S. Citizenship and Immigration Services Nomination of Chris Inglis to be National Cyber Director Nomination of Jen Easterly to be Cybersecurity and Infrastructure Security Agency Director Nomination of Robert Silvers to be the next Under Secretary of Office of Strategy, Policy, and Plans for the U.S. Department of Homeland Security Nomination of Jane Nishida to be Assistant Administrator for International and Tribal Affairs at the Environmental Protection Agency (EPA) Nomination of Michal Freedhoff to be Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP) at EPA Nomination of Radhika Fox to be Assistant Administrator of the Office of Water, EPA Nomination of Carlos Monje to be Under Secretary of Transportation for Policy Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Polly Trottenberg to be Deputy Secretary of Transportation Nomination of Don Graves to be Deputy Secretary of Commerce Nomination of Kenneth Polite to be Assistant Attorney General Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; False Claims Act and potential amendments related to materiality and disclosure of third-party funding; potential amendments to the Program Fraud Civil Remedies Act; Federal Trade Commission Act potential amendments to section 13(b); class action reform; antitrust; federal funding for state attorney general enforcement of antitrust laws; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; decisions of the Congressional Parliamentarians; implementation of the American Rescue Plan Act (P.L. 117-2); Paperwork Reduction Act (P.L. 96-511) compliance by Federal agencies and enforcement by the Office of Information and Regulatory Affairs; Modernizing Regulatory Review, Memorandum for the Heads of Executive Departments and Agencies (86 Fed. Reg. 7223, January 26, 2021)
Various issues relating to consumer protection issues relating to lawsuit advertising
H.R. 1087, Shareholder Political Transparency Act of 2021 H.R. 1187, Corporate Governance Improvement and Investor Protection Act H.R. 1277/S. 374, Improving Corporate Governance Through Diversity Act of 2021 H.R. 2025/S. 840, To amend title 28, United States Code, to increase transparency and oversight of third-party litigation funding in certain actions, and for other purposes H.R. 2516, Promoting Diversity and Inclusion in Banking Act of 2021 H.R. 2543, Federal Reserve Racial and Economic Equity Act H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2570, Climate Risk Disclosure Act of 2021 H.R. 3007, Disclosure of Tax Havens and Offshoring Act H.R. 3412, To amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act H.R. 3448, Helping Startups Continue to Grow Act H.R. 3454, Modernizing Disclosures for Investors Act S.J. Res. 15, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders" Draft legislation titled Adjustable Interest Rate Act of 2021 Potential legislation similar to S. 4129, Lifting Our Communities through Advance Liquidity for (LOCAL) Infrastructure Act (116th Congress) Potential legislation to foster economic growth and job creation through capital formation; Agency Information Collection Activities, Comment Request (86 Fed. Reg. 17,664, April 5, 2021) Proposed rule on Beneficial Ownership Information Reporting Requirements (86 Fed. Reg. 17,557 - 17,565, April 5, 2021) Proposed rule on CFPB Rulemaking, Protections for Borrowers Affected by the COVID-19 Emergency Under the Real Estate Settlement Procedures Act (RESPA), Regulation X (86 Fed. Reg, 18,840 - 18,881, April 9, 2021) Interim Final Rule on Holding Foreign Companies Accountable Act Disclosure (86 Fed. Reg. 17,528 - 17,543, April 5, 2021) Proposed rule and Reopening of Comment Period for Universal Proxy (86 Fed. Reg. 24,364 - 24,368, May 6, 2021) Various issues relating to SEC Best Interest and Enhancing Investment Adviser Regulation relating to broker-dealers, registered investment advisers, conflicts of interest; potential federal preemption of state fiduciary standards; Public Company Accounting Oversight Board (PCAOB); Appointment of Dr. Zoe-Vonna Palmrose to serve as a member of the Standards Advisory Group (SAG) at the Public Company Accounting Oversight Board (PCAOB); CFTCs de minimis Exception for Swap Dealers; CFPB regulatory sandbox for disclosures; Securities and Exchange Commission amendments to the Commissioners whistleblower rules file no. S7-16-18; proxy process, proxy advisory firms, and other related aspects of corporate governance; corporate common ownership; adoption of the current expected credit loss (CECL) accounting standard; role of credit reporting agencies (CRAs) in the U.S. economy; debt collection practices (regulation F) under the Fair Debt Collection Practices Act (P.L. 95-109); qualified mortgage definition under the Truth in Lending Act (P.L. 90-321) Regulation Z; Financial Stability Oversight Council and the designation of nonbank financial firms as systemically important; Federal Reserve Systems large institution supervision coordinating committee; potential housing finance reform legislation; enforcement of Securities and Exchange Commission penalties; EU sustainable finance action plan and incorporating ESG factors into financial services; EU review of Alternative Investment Fund Managers Directive; EU review of prudential regime for investment firms; transition from London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR); potential repeal of the State and Local Tax (SALT) Cap; federal interest rate authority; Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) reform; electronic consent-based SSN Verification Service (eCBSV); environmental, social, and governance (ESG) enforcement; information Collection under the Community Reinvestment Act (CRA); potential Financial Transaction Tax (FTT); investment company cross trading; potential money market fund reform measures; resolutions to establish task forces on Artificial Intelligence and Financial Technology in the House Committee on Financial Services; transition to the secured overnight financing rate; implementation and enforcement of Regulation Best Interest by the Securities and Exchange Commission; changes in the enforcement policies of the Securities and Exchange Commission; activity of the Financial Stability Oversight Council and recommendations on macro-prudential regulation; clarification in the regulatory treatment of digital assets by the Securities and Exchange Commission and the Commodity Futures Trading Commission; implementation and enforcement of proxy advisory firm regulations finalized in 2020; implementation and enforcement of SEC 14a-8 shareholder proposal process reforms finalized in 2020; EU money market fund regulation, legislative review; electronic delivery of certain investment documents and disclosures; implementation of beneficial ownership reporting requirements under the National Defense Authorization Act FY 2021 (P.L. 116-283); implementation of the Social Security Administrations Electronic Consent Based Social Security Number Verification System Service; SEC request for information on climate disclosures; SEC reforms to money market funds regulations; potential legislation related to securities litigation; COVID related securities litigation; Supreme Courts Cyan decision; potential legislation dealing with third party litigation financing and lawsuit lending; potential legislation related to securities litigation
H.R. 2096, Stop shielding Assets from Corporate Known Liability by Eliminating non-debtor Releases (SACKLER) Act Potential legislation similar to S. 766, Providing Responsible Oversight of Trusts to Ensure Compensation and Transparency (PROTECT) Asbestos Victims Act of 2019 Various issues relating to the U.S. Trustees authority to oversee the administration of bankruptcy trust funds; litigation bankruptcy trusts
Filing targets: Agriculture, Dept of (USDA), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
CHAMBER OF COMMERCE OF THE U.S.A. via CHAMBER OF COMMERCE OF THE U.S.A.
2021 · first_quarter · Q1
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1319, American Rescue Plan Act of 2021 S. 742, A bill to modify the exemption for trade secrets and commercial or financial information in the Freedom of Information Act, and for other purposes Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Potential legislation relating to sexual assault, sexual harassment and arbitration issues Nomination of Lisa Monaco to be Deputy Attorney General Nomination of Merrick Garland to be Attorney General Petition for rulemaking on support for COVID-19 related litigation - File 4-766; Various issues relating to liability relief due to the coronavirus pandemic; comments on support for petition for rulemaking on COVID-19 related litigation - File 4-766; Background on and preservation of Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
H.R. 847, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1319, American Rescue Plan Act of 2021, including provisions relating to the Technology Modernization Fund and broadband H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 224, Promoting Digital Privacy Technologies Act FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST) Draft legislation titled Information Transparency & Personal Data Control Act Draft legislation titled Endless Frontier Act Draft legislation titled Data Care Act Draft legislation titled FTC Procedural Reform Potential legislation similar to H.R. 8975, Deceptive Experiences To Online Users Reduction (DETOUR) Act (116th Congress) Potential legislation related to the regulation of facial recognition technology Comments on Allowing Earlier Equipment Marketing and Importation Opportunities (86 Fed. Reg. 2337) Comments on Modernizing the FCC Form 477 Data Program (85 Fed. Reg. 50886) (No. 11-10) Comments on Protecting Against National Security Threats to the Communications Supply Chain Through FCC Programs (86 Fed. Reg. 15165) (No. 18-89) Comments on Establishing the Digital Opportunity Data Collection (85 Fed. Reg. 50886) (No. 19-195) Comments on COVID-19 Telehealth Program Application Evaluation Metrics (86 Fed. Reg. 8356) (No. 20-89) Comments on Emergency Broadband Connectivity Fund Assistance (86 Fed. Reg. 19532) (No. 20-445) Comments on Petitions for Emergency Relief to Allow the Use of E-Rate Funds to Support Remote Learning During the COVID-19 Pandemic (86 Fed. Reg. 9309) (No. 21-31) Comments on securing the information and communications technology and services supply chain (86 FR 4909) Funding for implementation of the CHIPS for America Act (enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); Various issues relating to high speed broadband internet service; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC enforcement; FTC section 13(b); FCC petition regarding importation and marketing of radiofrequency devices; use of E-rate funding for the homework gap; FCC implementation of the emergency broadband benefit; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) NISTIR guidance on Federal Internet of Things Device Cybersecurity; FCCs COVID-19 telehealth program; OMBs memorandum on the Guidance for Regulation of Artificial Intelligence Applications; artificial intelligence regulation, standards, research and development; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
Potential legislation similar to S. 766, Providing Responsible Oversight of Trusts to Ensure Compensation and Transparency (PROTECT) Asbestos Victims Act of 2019 Various issues relating to the U.S. Trustees authority to oversee the administration of bankruptcy trust funds; litigation bankruptcy trusts
Various issues relating to reform of New York scaffold law
Various issues relating to data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising
Filing targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
CHAMBER OF COMMERCE OF THE U.S.A. via CHAMBER OF COMMERCE OF THE U.S.A.
2020 · fourth_quarter · Q4
H.R. 739, Cyber Diplomacy Act of 2019 H.R. 946, Stopping Bad Robocalls Act H.R. 1644, Save the Internet Act of 2019 H.R. 2013, Information Transparency & Personal Data Control Act H.R. 2202, Growing Artificial Intelligence Through Research (GrAITR) Act H.R. 2575/S. 1363, AI in Government Act of 2019 H.R. 3086/S. 1585, Respond, Innovate, Succeed, and Empower (RISE) Act of 2019 H.R. 3156, Smart Technologies Advancing Reliable Transportation (START) Act H.R. 3262/H.R. 4686/ S. 1871, Sami's Law H.R. 4027, Stop the Censorship Act H.R. 4978, Online Privacy Act of 2019 H.R. 5703, Protecting the Information of our Vulnerable Children and Youth (PRIVCY) Act H.R. 6145/S. 3191, Industries of the Future Act of 2020 H.R. 6216, National Artificial Intelligence Initiative Act of 2020 H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 7308/ S. 4286, Research Investment to Spark the Economy (RISE) Act H.R. 7608, State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021 H.R. 8048, State and Local IT Modernization and Cybersecurity Act H.R. 8132, American Competitiveness Of a More Productive Emerging Tech Economy (American COMPETE) Act H.R. 8517, Protect Speech Act H.R. 8636, Protecting Americans from Dangerous Algorithms Act S. 142, American Data Dissemination (ADD) Act of 2019 S. 189, Social Media Privacy Protection and Consumer Rights Act of 2019 S. 583, Digital Accountability and Transparency to Advance (DATA) Privacy Act S. 748, A bill to amend the Children's Online Privacy Protection Act of 1998 to strengthen protections relating to the online collection, use, and disclosure of personal information of children and minors, and for other purposes S. 783, Clean Slate for Kids Online Act of 2019 S. 847, Commercial Facial Recognition Privacy Act of 2019 S. 1084, Deceptive Experiences To Online Users Reduction (DETOUR) Act S. 1116, Balancing the Rights Of Web Surfers Equally and Responsibly (BROWSER) Act of 2019 S. 1214, Privacy Bill of Rights Act S. 1558, Artificial Intelligence Initiative Act S. 1578, Do Not Track Act S. 1611, Developing Innovation and Growing the Internet of Things (DIGIT) Act S. 1914, Ending Support for Internet Censorship Act S. 2775, Harvesting American Cybersecurity Knowledge through Education (HACKED) Act of 2019 S. 2763, Filter Bubble Transparency Act S. 2878, Facial Recognition Technology Warrant Act of 2019 S. 2968, Consumer Online Privacy Rights Act S. 3284, Ethical Use of Facial Recognition Act S. 3300, Data Protection Act of 2020 S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 S. 3456, Consumer Data Privacy and Security Act of 2020 S. 3663, COVID-19 Consumer Data Protection Act of 2020 S. 3712, Cybersecurity Competitions to Yield Better Efforts to Research the Latest Exceptionally Advanced Problems (Cyber Leap) Act of 2020 S. 3749, Public Health Emergency Privacy Act S. 3771, Fundamentally Understanding the Usability and Realistic Evolution (FUTURE) of Artificial Intelligence Act of 2020 S. 3832, Endless Frontier Act S. 3861, Exposure Notification Privacy Act S. 3891, Advancing Artificial Intelligence Research Act of 2020 S. 3983, A bill to amend the Communications Act of 1934 to provide accountability for bad actors who abuse the Good Samaritan protections provided under that Act, and for other purposes S. 4051, Lawful Access to Encrypted Data Act S. 4066, Platform Accountability and Consumer Transparency (PACT) Act S. 4159, E-SIGN Modernization Act of 2020 S. 4422, Connecting Minority Communities Act of 2020 S. 4626, Setting an American Framework to Ensure Data Access, Transparency, and Accountability (SAFE DATA) Act S. 4632, Online Content Policy Modernization Act S. 4758, See Something, Say Something Online Act of 2020 S. 5020, A bill to repeal section 230 of the Communications Act of 1934 H.Res. 294, Providing for consideration of the bill (H.R. 1644) to restore the open internet order of the Federal Communications Commission; providing for consideration of the bill (H.R. 2021) to amend the Balanced Budget and Emergency Deficit Control Act of 1985 and to establish a congressional budget for fiscal year 2020; and for other purposes Potential legislation similar to H.R.4625, FUTURE of Artificial Intelligence Act of 2017 Potential legislation related to the regulation of facial recognition technology Draft legislation titled FTC Procedural Reform Draft legislation titled United States Consumer Data Privacy Act of 2019 Proposed rule restoring internet freedom (82 Fed. Reg. 25,568-25,590, June 2, 2017) Proposed rule accelerating wireline broadband deployment by removing barriers to infrastructure investment (82 Fed. Reg. 22,453-22,474, May 16, 2017) Draft memorandum to the heads of executive departments and agencies, Guidance for Regulation of Artificial Intelligence Applications (85 Fed. Reg. 1,825, January 13, 2020); Various issues relating to high speed broadband internet service and resolving the homework gap by access to broadband for students; broadband infrastructure and deployment; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; potential legislation to establish a national privacy law; matter of streamlining deployment of small cell infrastructure by improving wireless sitting policies (FCC WT Docket No. 16-421); comments on refreshing of record in restoring internet freedom proceeding (WC Docket Nos. 17-108, 17-287, 11-42); facial recognition technology; net neutrality; privacy principles; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; FTC hearings on Competition and Consumer Protection; FTC data portability; FTC enforcement; FTC enforcement of section 13(b); FCC proposed radiofrequency marketing rule; reauthorization and appropriation for the National Institute of Standards and Technology (NIST); FY2021 Appropriations for the National Institute of Standards and Technology (NIST); comments on March 30, 2020 Petition for Expedited Declaratory Ruling, Clarification or Waiver Filed by the American Bankers Association, et al. - CG Docket Number 02-278; comments on National Institute of Standards and Technology (NIST) NISTIR 8259, recommendations for IoT device Manufacturers: Foundational Activities and Core Device Cybersecurity Capability Baseline (2nd Draft); comments on the National Telecommunications and Information Administrations request for public comment on proposals and positions for the 2020 World Telecommunication Standardization Assembly; funding for the NIST AI risk management framework; FCCs COVID-19 telehealth program; Indias non-personal data governance framework; comments to Department of Transportation on remote identifications of unmanned aerial systems proposed rule; Transportation Network Companies (TNCs) and the coronavirus pandemic; comments on Four Principles of Explainable Artificial Intelligence (Draft NISTIR 8312); petition to FCC Supporting Capital Ones TCPA Petition for Declaratory Ruling; inclusion of broadband funding in year-end appropriations legislation; implementation Section 2209 of the FAA Extension, Safety, and Security Act of 2016 (P.L. 114-190); potential nationalization of the 5G network; comments on OMBs Guidance for Regulation of Artificial Intelligence Applications; potential data privacy legislation; potential data aggregation legislation regarding section 1033 of Dodd-Frank Wall Street Reform and Consumer Protection Act (P.L. 111-203); potential legislation regarding artificial intelligence; artificial intelligence regulation, research and development; potential legislation regarding digital assets; fintech and digital asset strategy; data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising; implementation of Telephone Consumer Protection Act (TCPA) (P.L. 102-243)
Various issues relating to reform of New York scaffold law
S. 2968, Consumer Online Privacy Rights Act S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 S. 4051, Lawful Access to Encrypted Data Act S. 4066, Platform Accountability and Consumer Transparency (PACT) Act S. 4632, Online Content Policy Modernization Act S. 4758, See Something, Say Something Online Act of 2020 Various issues relating to data privacy; revisions to Communications Decency Act (P.L. 104-104, Title V); consumer protection issues relating to lawsuit advertising; implementation of Telephone Consumer Protection Act (TCPA) (P.L. 102-243)
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1423/S. 610, Forced Arbitration Injustice Repeal Act H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 2750, Justice for Servicemembers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 5326, Fairness in Nursing Home Arbitration Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 8222, Infrastructure Expansion Act of 2020 H.R. 8608, Carries Law S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; arbitration agreements and implementation of the Servicemembers Civil Relief Act (P.L. 108-189) and the Uniformed Services Employment and Reemployment Rights Act of 1994 (P.L. 103-353); implementation of Foreign Corrupt Practices Act (P.L. 95-213); implementation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation; asbestos risk assessment report
Filing targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
CHAMBER OF COMMERCE OF THE U.S.A. via CHAMBER OF COMMERCE OF THE U.S.A.
2020 · third_quarter · 3A
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Filing targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
CHAMBER OF COMMERCE OF THE U.S.A. via CHAMBER OF COMMERCE OF THE U.S.A.
2020 · third_quarter · 3A
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
Filing targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
CHAMBER OF COMMERCE OF THE U.S.A. via CHAMBER OF COMMERCE OF THE U.S.A.
2020 · third_quarter · Q3
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues
H.R. 327, Ending Forced Arbitration for Victims of Data Breaches Act of 2019 H.R. 1423/S. 601, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 1430/S. 608, Court Legal Access and Student Support (CLASS) Act of 2019 H.R. 1443, Ending Forced Arbitration of Sexual Harassment Act H.R. 1500, Consumers First Act H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 H.R. 2148/S. 1082, BE HEARD in the Workplace Act H.R. 2474/S. 1306, Protecting the Right to Organize Act of 2019 H.R. 2749/S. 1491, Restoring Justice for Workers Act H.R. 3843/S. 3026, General background on the Countering Russian and Other Overseas Kleptocracy Act H.R. 4140, General background on the Foreign Extortion Prevention Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 620, Safety Over Arbitration Act of 2019 S. 630, Arbitration Fairness for Consumers Act S. 635, Restoring Statutory Rights and Interests of the States Act of 2019 S. 1624, Help End Abusive Living Situations (HEALS) Act S. 2789, Satellite Television Access Reauthorization Act of 2019 S. 2968, Consumer Online Privacy Rights Act Potential legislation similar to H.R. 6351, Fairness in Nursing Home Arbitration Act of 2012 Various issues relating to liability relief due to the coronavirus pandemic; Background on and preservation of Federal Arbitration Act (P.L. 86-401); alternative dispute resolution mechanisms; litigation involving perfluoroalkyl substances (PFAS); legal reform; legislation related to sexual assault and arbitration; civil discovery reform; asbestos litigation; fraud and abuse in civil litigation
Filing targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office